Brevan Howard Capital Management’s PACS Group PACS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-9,167
Closed -$352K 2560
2025
Q4
$352K Buy
+9,167
New +$201K ﹤0.01% 1287
2025
Q3
Sell
-13,713
Closed -$177K 2347
2025
Q2
$177K Buy
+13,713
New +$143K ﹤0.01% 1732
2025
Q1
Sell
-26,502
Closed -$347K 1531
2024
Q4
$347K Buy
26,502
+20,476
+340% +$525K ﹤0.01% 731
2024
Q3
$241K Buy
+6,026
New +$219K ﹤0.01% 933

Other funds holding PACS

Brevan Howard Capital Management's PACS Position: Q1 2026 in Review

Brevan Howard Capital Management sold out of PACS Group (PACS) in Q1 2026, closing a stake of 9,167 shares — an estimated $352K sold.

Brevan Howard Capital Management first reported a position in PACS in Q3 2024 and held it in 4 quarters. The position peaked at $352K in Q4 2025. 217 funds tracked by Wall St. Rank hold PACS as of Q1 2026.

  • Brevan Howard Capital Management reported no remaining PACS Group position as of Q1 2026 after selling out during the quarter.
  • Brevan Howard Capital Management sold 9,167 PACS Group shares in Q1 2026, an estimated $352K.
  • Brevan Howard Capital Management first reported a position in PACS Group in Q3 2024 and held it in 4 quarters.
  • Brevan Howard Capital Management's PACS Group position peaked at $352K in Q4 2025.
  • 217 funds tracked by Wall St. Rank held PACS Group as of Q1 2026.

Based on Brevan Howard Capital Management's 13F filing for Q1 2026, filed 15 May 2026.